Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 10.6931 | 99 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 11.0158 | 99 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 10.5389 | 98 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 11.1826 | 99 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 11.3822 | 99 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 10.485 | 98 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 10.5731 | 99 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 10.8202 | 99 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 10.7153 | 99 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 9.92229 | 98 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 9.85699 | 98 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 10.2297 | 98 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 10.2841 | 98 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 9.9762 | 98 |